Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beams: Short-Course Regimen for Drug-Susceptible TB
NCT07129629Phase 2Not yet recruiting
- Sponsor
- Shanghai Pulmonary Hospital
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of bedaquiline in pulmonary tuberculosis (TB), sponsored by Shanghai Pulmonary Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
bedaquiline
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT07129629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07129629.